IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis
Open Access
- 1 October 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 185 (7) , 4354-4362
Abstract
Psoriasis is a common immune-mediated disease in European populations; it is characterized by inflammation and altered epidermal differentiation leading to redness and scaling. T cells are thought to be the main driver, but there is also evidence for an epidermal contribution. In this article, we show that treatment of mouse skin overexpressing the IL-1 family member, IL-1F6, with phorbol ester leads to an inflammatory condition with macroscopic and histological similarities to human psoriasis. Inflammatory cytokines thought to be important in psoriasis, such as TNF-α, IL-17A, and IL-23, are upregulated in the mouse skin. These cytokines are induced by and can induce IL-1F6 and related IL-1 family cytokines. Inhibition of TNF or IL-23 inhibits the increased epidermal thickness, inflammation, and cytokine production. Blockade of IL-1F6 receptor also resolves the inflammatory changes in human psoriatic lesional skin transplanted onto immunodeficient mice. These data suggest a role for IL-1F family members in psoriasis.Keywords
This publication has 63 references indexed in Scilit:
- Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasisNature Genetics, 2009
- Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic CellsJournal of Investigative Dermatology, 2009
- Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathwaysBritish Journal of Dermatology, 2008
- Genetically Programmed Differences in Epidermal Host Defense between Psoriasis and Atopic Dermatitis PatientsPLOS ONE, 2008
- Psoriasis is associated with increased β-defensin genomic copy numberNature Genetics, 2007
- Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammationJournal of Experimental Medicine, 2007
- A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk GenesThe American Journal of Human Genetics, 2007
- Interleukin-23 drives innate and T cell–mediated intestinal inflammationJournal of Experimental Medicine, 2006
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesJournal of Experimental Medicine, 2006
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003